Chemours Company
(CC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 5,526,000 | 6,638,000 | 6,183,000 | 5,400,000 | 5,717,000 |
| Cost of Goods | 4,463,000 | 4,667,000 | 4,438,000 | 4,297,000 | 4,762,000 |
| Gross Profit | 1,063,000 | 1,971,000 | 1,745,000 | 1,103,000 | 955,000 |
| Operating Expenses | 715,000 | 788,000 | 764,000 | 1,197,000 | 1,087,000 |
| Operating Income | 348,000 | 1,183,000 | 981,000 | -94,000 | -132,000 |
| Interest Expense | 208,000 | 195,000 | 214,000 | 219,000 | 132,000 |
| Other Income | -264,000 | 167,000 | 145,000 | 302,000 | 76,000 |
| Pre-tax Income | -124,000 | 1,155,000 | 912,000 | -11,000 | -188,000 |
| Income Tax | -72,000 | 159,000 | 165,000 | -18,000 | -98,000 |
| Net Income Continuous | -52,000 | 996,000 | 747,000 | 7,000 | -90,000 |
| Minority Interests | N/A | 1,000 | 1,000 | N/A | N/A |
| Net Income | $-52,000 | $995,000 | $746,000 | $7,000 | $-90,000 |
| EPS Basic Total Ops | -0.32 | 5.62 | 4.04 | 0.04 | -0.50 |
| EPS Basic Continuous Ops | -0.32 | 5.63 | 4.04 | 0.04 | -0.50 |
| EPS Diluted Total Ops | -0.32 | 5.45 | 3.91 | 0.04 | -0.50 |
| EPS Diluted Continuous Ops | -0.32 | 5.46 | 3.91 | 0.04 | -0.50 |
| EPS Diluted Before Non-Recurring Items | 2.51 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $668,000 | $1,478,000 | $1,267,000 | $206,000 | $143,000 |